BH3-mimetics--the solution to chemoresistance?
Khaw
Seong L
SL
Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia. khaw@wehi.edu.au
Huang
David C S
DC
Roberts
Andrew W
AW
D000970:Antineoplastic Agents / Q000494:pharmacology; D017209:Apoptosis; D040761:Biomimetic Materials / Q000494:pharmacology*; D045744:Cell Line, Tumor; D019008:Drug Resistance, Neoplasm; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008928:Mitochondria / Q000187:drug effects; D014411:Neoplastic Stem Cells; D010446:Peptide Fragments / Q000737:chemistry; D011379:Prognosis; D011518:Proto-Oncogene Proteins / Q000737:chemistry; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism
D000970:Antineoplastic Agents; C474007:Bax protein (53-86); D010446:Peptide Fragments; D011518:Proto-Oncogene Proteins; D019253:Proto-Oncogene Proteins c-bcl-2